Description

Semaglutide Overview

Semaglutide is a synthetic research peptide structurally designed as an analog of glucagon-like peptide-1 (GLP-1). It is widely studied in laboratory settings for its role in peptide–receptor interactions and incretin pathway signaling. Preclinical research often explores Semaglutide’s metabolic activity, peptide pharmacokinetics, and stability compared to natural GLP-1 analogs.

Product Details

• Sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLRGRG

• Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉

• Molecular Weight: 4113.64 g/mol

• PubChem CID: 56843331

• CAS Number: 910463-68-2

Research Highlights

• GLP-1 Receptor Interaction: Extensively studied for its activity on GLP-1 receptors and role in cellular signaling pathways.

• Peptide Stability: Investigated for its extended half-life and enhanced resistance to enzymatic degradation compared to native GLP-1.

• Pharmacokinetics: Utilized in research assessing controlled-release mechanisms, absorption, and bioavailability in preclinical models.

• Metabolic Pathway Modeling: Applied in studies modeling glucose regulation and related signaling pathways in vitro and in vivo.

Usage and Safety Information

This peptide is intended strictly for laboratory research use only. It is not approved for human, medical, or veterinary use. Proper safety procedures and handling protocols must be observed when working with this compound.

Important Notices

• Supplied exclusively for scientific research purposes.

• Provided as a lyophilized (freeze-dried) powder in a sterile, sealed vial.

• Label quantity indicates the total amount of peptide per vial.

• Requires additional laboratory materials such as bacteriostatic water for reconstitution, sterile syringes, needles, and alcohol prep pads.

• Vial appearance, label, seal, and cap colors may vary from product images.